><title>References</title><ref id="ppat.1002480-Nagai1"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagai</surname><given-names>M</given-names></name><name><surname>Osame</surname><given-names>M</given-names></name></person-group>
<year>2003</year>
<article-title>Human T-cell lymphotropic virus type I and neurological diseases.</article-title>
<source>J Neurovirol</source>
<volume>9</volume>
<fpage>228</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="pmid">12707853</pub-id></element-citation></ref><ref id="ppat.1002480-Manel1"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manel</surname><given-names>N</given-names></name><name><surname>Battini</surname><given-names>JL</given-names></name><name><surname>Taylor</surname><given-names>N</given-names></name><name><surname>Sitbon</surname><given-names>M</given-names></name></person-group>
<year>2005</year>
<article-title>HTLV-1 tropism and envelope receptor.</article-title>
<source>Oncogene</source>
<volume>24</volume>
<fpage>6016</fpage>
<lpage>6025</lpage>
<pub-id pub-id-type="pmid">16155608</pub-id></element-citation></ref><ref id="ppat.1002480-Bangham1"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bangham</surname><given-names>CR</given-names></name></person-group>
<year>2000</year>
<article-title>The immune response to HTLV-I.</article-title>
<source>Curr Opin Immunol</source>
<volume>12</volume>
<fpage>397</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="pmid">10899027</pub-id></element-citation></ref><ref id="ppat.1002480-Iwasaki1"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>Y</given-names></name><name><surname>Ohara</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>I</given-names></name><name><surname>Akizuki</surname><given-names>S</given-names></name></person-group>
<year>1992</year>
<article-title>Infiltration of helper inducer lymphocytes-T heralds central-nervous-system damage in Human T-cell Leukemia-Virus infection.</article-title>
<source>Am J Pathol</source>
<volume>140</volume>
<fpage>1003</fpage>
<lpage>1008</lpage>
<pub-id pub-id-type="pmid">1374584</pub-id></element-citation></ref><ref id="ppat.1002480-Hauser1"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hauser</surname><given-names>SL</given-names></name><name><surname>Oksenberg</surname><given-names>JR</given-names></name></person-group>
<year>2006</year>
<article-title>The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.</article-title>
<source>Neuron</source>
<volume>52</volume>
<fpage>61</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">17015227</pub-id></element-citation></ref><ref id="ppat.1002480-Nagai2"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagai</surname><given-names>M</given-names></name><name><surname>Usuku</surname><given-names>K</given-names></name><name><surname>Matsumoto</surname><given-names>W</given-names></name><name><surname>Kodama</surname><given-names>D</given-names></name><name><surname>Takenouchi</surname><given-names>N</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.</article-title>
<source>J Neurovirol</source>
<volume>4</volume>
<fpage>586</fpage>
<lpage>593</lpage>
<pub-id pub-id-type="pmid">10065900</pub-id></element-citation></ref><ref id="ppat.1002480-Goon1"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goon</surname><given-names>PKC</given-names></name><name><surname>Hanon</surname><given-names>E</given-names></name><name><surname>Igakura</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Weber</surname><given-names>JN</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>High frequencies of Th1-type CD4(&#x0002b;) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.</article-title>
<source>Blood</source>
<volume>99</volume>
<fpage>3335</fpage>
<lpage>3341</lpage>
<pub-id pub-id-type="pmid">11964301</pub-id></element-citation></ref><ref id="ppat.1002480-Toulza1"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toulza</surname><given-names>F</given-names></name><name><surname>Heaps</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Taylor</surname><given-names>GP</given-names></name><name><surname>Bangham</surname><given-names>CRM</given-names></name></person-group>
<year>2008</year>
<article-title>High frequency of CD4(&#x0002b;)FoxP3(&#x0002b;) cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response.</article-title>
<source>Blood</source>
<volume>111</volume>
<fpage>5047</fpage>
<lpage>5053</lpage>
<pub-id pub-id-type="pmid">18094326</pub-id></element-citation></ref><ref id="ppat.1002480-Yu1"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Itoyama</surname><given-names>Y</given-names></name><name><surname>Fujihara</surname><given-names>K</given-names></name><name><surname>Goto</surname><given-names>I</given-names></name></person-group>
<year>1991</year>
<article-title>Natural-killer (NK) cells in HTLV-I-associated myelopathy tropical spastic paraparesis - decrease in NK cell subset populations and activity in HTLV-I seropositive individuals J Neurovirol</article-title>
<volume>33</volume>
<fpage>121</fpage>
<lpage>128</lpage>
</element-citation></ref><ref id="ppat.1002480-Yamano1"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamano</surname><given-names>Y</given-names></name><name><surname>Nagai</surname><given-names>M</given-names></name><name><surname>Brennan</surname><given-names>M</given-names></name><name><surname>Mora</surname><given-names>CA</given-names></name><name><surname>Soldan</surname><given-names>SS</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(&#x0002b;) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).</article-title>
<source>Blood</source>
<volume>99</volume>
<fpage>88</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">11756157</pub-id></element-citation></ref><ref id="ppat.1002480-Meekings1"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meekings</surname><given-names>KN</given-names></name><name><surname>Leipzig</surname><given-names>J</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><name><surname>Taylor</surname><given-names>GP</given-names></name><name><surname>Bangham</surname><given-names>CR</given-names></name></person-group>
<year>2008</year>
<article-title>HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP.</article-title>
<source>PLoS Pathog</source>
<volume>4</volume>
<fpage>e1000027</fpage>
<pub-id pub-id-type="pmid">18369476</pub-id></element-citation></ref><ref id="ppat.1002480-Berry1"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berry</surname><given-names>MPR</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>ZH</given-names></name><name><surname>Bloch</surname><given-names>SAA</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.</article-title>
<source>Nature</source>
<volume>466</volume>
<fpage>973-U998</fpage>
<pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="ppat.1002480-Pascual1"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pascual</surname><given-names>V</given-names></name><name><surname>Chaussabel</surname><given-names>D</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name></person-group>
<year>2010</year>
<article-title>A genomic approach to human autoimmune diseases.</article-title>
<source>Annu Rev Immunol</source>
<volume>28</volume>
<fpage>535</fpage>
<lpage>571</lpage>
<pub-id pub-id-type="pmid">20192809</pub-id></element-citation></ref><ref id="ppat.1002480-Ramilo1"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramilo</surname><given-names>O</given-names></name><name><surname>Allman</surname><given-names>W</given-names></name><name><surname>Chung</surname><given-names>W</given-names></name><name><surname>Mejias</surname><given-names>A</given-names></name><name><surname>Ardura</surname><given-names>M</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Gene expression patterns in blood leukocytes discriminate patients with acute infections.</article-title>
<source>Blood</source>
<volume>109</volume>
<fpage>2066</fpage>
<lpage>2077</lpage>
<pub-id pub-id-type="pmid">17105821</pub-id></element-citation></ref><ref id="ppat.1002480-Richardson1"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richardson</surname><given-names>JH</given-names></name><name><surname>Edwards</surname><given-names>AJ</given-names></name><name><surname>Cruickshank</surname><given-names>JK</given-names></name><name><surname>Rudge</surname><given-names>P</given-names></name><name><surname>Dalgleish</surname><given-names>AG</given-names></name></person-group>
<year>1990</year>
<article-title>Invivo cellular tropism of Human T-cell Leukemia-Virus Type-1.</article-title>
<source>J Virol</source>
<volume>64</volume>
<fpage>5682</fpage>
<lpage>5687</lpage>
<pub-id pub-id-type="pmid">1976827</pub-id></element-citation></ref><ref id="ppat.1002480-Oliere1"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oliere</surname><given-names>S</given-names></name><name><surname>Hernandez</surname><given-names>E</given-names></name><name><surname>Lezin</surname><given-names>A</given-names></name><name><surname>Arguello</surname><given-names>M</given-names></name><name><surname>Douville</surname><given-names>R</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).</article-title>
<source>PLoS Pathog</source>
<volume>6</volume>
<fpage>e1001177</fpage>
<pub-id pub-id-type="pmid">21079688</pub-id></element-citation></ref><ref id="ppat.1002480-Fung1"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fung</surname><given-names>MM</given-names></name><name><surname>Chu</surname><given-names>YL</given-names></name><name><surname>Fink</surname><given-names>JL</given-names></name><name><surname>Wallace</surname><given-names>A</given-names></name><name><surname>McGuire</surname><given-names>KL</given-names></name></person-group>
<year>2005</year>
<article-title>IL-2- and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1.</article-title>
<source>Oncogene</source>
<volume>24</volume>
<fpage>4624</fpage>
<lpage>4633</lpage>
<pub-id pub-id-type="pmid">15735688</pub-id></element-citation></ref><ref id="ppat.1002480-Suzuki1"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Refaat</surname><given-names>A</given-names></name><name><surname>Takasaki</surname><given-names>I</given-names></name><name><surname>Koizumi</surname><given-names>K</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Human T Cell Lymphotropic Virus 1 Manipulates Interferon Regulatory Signals by Controlling the TAK1-IRF3 and IRF4 Pathways.</article-title>
<source>J Biol Chem</source>
<volume>285</volume>
<fpage>4441</fpage>
<lpage>4446</lpage>
<pub-id pub-id-type="pmid">19955181</pub-id></element-citation></ref><ref id="ppat.1002480-Baba1"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baba</surname><given-names>M</given-names></name><name><surname>Okamoto</surname><given-names>M</given-names></name><name><surname>Hamasaki</surname><given-names>T</given-names></name><name><surname>Horai</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells.</article-title>
<source>J Virol</source>
<volume>82</volume>
<fpage>3843</fpage>
<lpage>3852</lpage>
<pub-id pub-id-type="pmid">18256142</pub-id></element-citation></ref><ref id="ppat.1002480-Rahman1"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahman</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>ZK</given-names></name><name><surname>Wigdahl</surname><given-names>B</given-names></name><name><surname>Jennings</surname><given-names>SR</given-names></name><name><surname>Tangy</surname><given-names>F</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection.</article-title>
<source>J Immunol</source>
<volume>186</volume>
<fpage>390</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="pmid">21115731</pub-id></element-citation></ref><ref id="ppat.1002480-Refaat1"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Refaat</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Takasaki</surname><given-names>I</given-names></name><name><surname>Koizumi</surname><given-names>K</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9.</article-title>
<source>J Biol Chem</source>
<volume>286</volume>
<fpage>21092</fpage>
<lpage>21099</lpage>
<pub-id pub-id-type="pmid">21498517</pub-id></element-citation></ref><ref id="ppat.1002480-Bangham2"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bangham</surname><given-names>CR</given-names></name><name><surname>Meekings</surname><given-names>K</given-names></name><name><surname>Toulza</surname><given-names>F</given-names></name><name><surname>Nejmeddine</surname><given-names>M</given-names></name><name><surname>Majorovits</surname><given-names>E</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>The immune control of HTLV-1 infection: selection forces and dynamics.</article-title>
<source>Front Biosci</source>
<volume>14</volume>
<fpage>2889</fpage>
<lpage>2903</lpage>
</element-citation></ref><ref id="ppat.1002480-Jeffery1"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>KJM</given-names></name><name><surname>Usuku</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>SE</given-names></name><name><surname>Matsumoto</surname><given-names>W</given-names></name><name><surname>Taylor</surname><given-names>GP</given-names></name><etal/></person-group>
<year>1999</year>
<article-title>HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>96</volume>
<fpage>3848</fpage>
<lpage>3853</lpage>
<pub-id pub-id-type="pmid">10097126</pub-id></element-citation></ref><ref id="ppat.1002480-Zhang1"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhi</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Kuo</surname><given-names>YL</given-names></name><name><surname>Giam</surname><given-names>CZ</given-names></name></person-group>
<year>2009</year>
<article-title>Induction of p21(CIP1/WAF1) expression by human T-lymphotropic virus type 1 Tax requires transcriptional activation and mRNA stabilization.</article-title>
<source>Retrovirology</source>
<volume>6</volume>
<fpage>35</fpage>
<pub-id pub-id-type="pmid">19356250</pub-id></element-citation></ref><ref id="ppat.1002480-Krueger1"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krueger</surname><given-names>A</given-names></name><name><surname>Fas</surname><given-names>SC</given-names></name><name><surname>Giaisi</surname><given-names>M</given-names></name><name><surname>Bleumink</surname><given-names>M</given-names></name><name><surname>Merling</surname><given-names>A</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>HTLV-1 tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).</article-title>
<source>Blood</source>
<volume>107</volume>
<fpage>3933</fpage>
<lpage>3939</lpage>
<pub-id pub-id-type="pmid">16403915</pub-id></element-citation></ref><ref id="ppat.1002480-Mochizuki1"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mochizuki</surname><given-names>M</given-names></name><name><surname>Tajima</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Yamaguchi</surname><given-names>K</given-names></name></person-group>
<year>1994</year>
<article-title>Human T lymphotropic virus type 1 uveitis.</article-title>
<source>Br J Ophthalmol</source>
<volume>78</volume>
<fpage>149</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="pmid">8123625</pub-id></element-citation></ref><ref id="ppat.1002480-Gandhi1"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>KS</given-names></name><name><surname>McKay</surname><given-names>FC</given-names></name><name><surname>Cox</surname><given-names>M</given-names></name><name><surname>Riveros</surname><given-names>C</given-names></name><name><surname>Armstrong</surname><given-names>N</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis.</article-title>
<source>Hum Mol Gen</source>
<volume>19</volume>
<fpage>2134</fpage>
<lpage>2143</lpage>
<pub-id pub-id-type="pmid">20190274</pub-id></element-citation></ref><ref id="ppat.1002480-Chaussabel1"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chaussabel</surname><given-names>D</given-names></name><name><surname>Quinn</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Glaser</surname><given-names>C</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus.</article-title>
<source>Immunity</source>
<volume>29</volume>
<fpage>150</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="pmid">18631455</pub-id></element-citation></ref><ref id="ppat.1002480-Guerreiro1"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guerreiro</surname><given-names>JB</given-names></name><name><surname>Santos</surname><given-names>SB</given-names></name><name><surname>Morgan</surname><given-names>DJ</given-names></name><name><surname>Porto</surname><given-names>AF</given-names></name><name><surname>Muniz</surname><given-names>AL</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.</article-title>
<source>Clin Exp Immunol</source>
<volume>145</volume>
<fpage>296</fpage>
<lpage>301</lpage>
<pub-id pub-id-type="pmid">16879249</pub-id></element-citation></ref><ref id="ppat.1002480-Narikawa1"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Narikawa</surname><given-names>K</given-names></name><name><surname>Fujihara</surname><given-names>K</given-names></name><name><surname>Misu</surname><given-names>T</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Fujimori</surname><given-names>J</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.</article-title>
<source>J Neuroimmunol</source>
<volume>159</volume>
<fpage>177</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="pmid">15652417</pub-id></element-citation></ref><ref id="ppat.1002480-Hall1"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hall</surname><given-names>JC</given-names></name><name><surname>Rosen</surname><given-names>A</given-names></name></person-group>
<year>2010</year>
<article-title>Type I interferons: crucial participants in disease amplification in autoimmunity.</article-title>
<source>Nat Rev Rheumatol</source>
<volume>6</volume>
<fpage>40</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="pmid">20046205</pub-id></element-citation></ref><ref id="ppat.1002480-Randall1"><label>32</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Randall</surname><given-names>RE</given-names></name><name><surname>Goodbourn</surname><given-names>S</given-names></name></person-group>
<year>2008</year>
<article-title>Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.</article-title>
<source>J Gen Virol</source>
<volume>89</volume>
<fpage>1</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="pmid">18089727</pub-id></element-citation></ref><ref id="ppat.1002480-Samarajiwa1"><label>33</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Samarajiwa</surname><given-names>SA</given-names></name><name><surname>Forster</surname><given-names>S</given-names></name><name><surname>Auchettl</surname><given-names>K</given-names></name><name><surname>Hertzog</surname><given-names>PJ</given-names></name></person-group>
<year>2009</year>
<article-title>INTERFEROME: the database of interferon regulated genes.</article-title>
<source>Nucleic Acids Res</source>
<volume>37</volume>
<fpage>D852</fpage>
<lpage>857</lpage>
<pub-id pub-id-type="pmid">18996892</pub-id></element-citation></ref><ref id="ppat.1002480-Harris1"><label>34</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harris</surname><given-names>JM</given-names></name><name><surname>Chess</surname><given-names>RB</given-names></name></person-group>
<year>2003</year>
<article-title>Effect of pegylation on pharmaceuticals.</article-title>
<source>Nat Rev Drug Discov</source>
<volume>2</volume>
<fpage>214</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">12612647</pub-id></element-citation></ref><ref id="ppat.1002480-Li1"><label>35</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>JL</given-names></name><name><surname>Hu</surname><given-names>SX</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Interferon Lambda Inhibits Herpes Simplex Virus Type I Infection of Human Astrocytes and Neurons.</article-title>
<source>Glia</source>
<volume>59</volume>
<fpage>58</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="pmid">20878770</pub-id></element-citation></ref><ref id="ppat.1002480-vanderPouwKraan1"><label>36</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van der Pouw Kraan</surname><given-names>TC</given-names></name><name><surname>Wijbrandts</surname><given-names>CA</given-names></name><name><surname>van Baarsen</surname><given-names>LG</given-names></name><name><surname>Voskuyl</surname><given-names>AE</given-names></name><name><surname>Rustenburg</surname><given-names>F</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.</article-title>
<source>Ann Rheum Dis</source>
<volume>66</volume>
<fpage>1008</fpage>
<lpage>1014</lpage>
<pub-id pub-id-type="pmid">17223656</pub-id></element-citation></ref><ref id="ppat.1002480-Baechler1"><label>37</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baechler</surname><given-names>EC</given-names></name><name><surname>Batliwalla</surname><given-names>FM</given-names></name><name><surname>Karypis</surname><given-names>G</given-names></name><name><surname>Gaffney</surname><given-names>PM</given-names></name><name><surname>Ortmann</surname><given-names>WA</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>100</volume>
<fpage>2610</fpage>
<lpage>2615</lpage>
<pub-id pub-id-type="pmid">12604793</pub-id></element-citation></ref><ref id="ppat.1002480-Assassi1"><label>38</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Assassi</surname><given-names>S</given-names></name><name><surname>Mayes</surname><given-names>MD</given-names></name><name><surname>Arnett</surname><given-names>FC</given-names></name><name><surname>Gourh</surname><given-names>P</given-names></name><name><surname>Agarwal</surname><given-names>SK</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Systemic sclerosis and lupus: points in an interferon-mediated continuum.</article-title>
<source>Arthritis Rheum</source>
<volume>62</volume>
<fpage>589</fpage>
<lpage>598</lpage>
<pub-id pub-id-type="pmid">20112391</pub-id></element-citation></ref><ref id="ppat.1002480-Emamian1"><label>39</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Emamian</surname><given-names>ES</given-names></name><name><surname>Leon</surname><given-names>JM</given-names></name><name><surname>Lessard</surname><given-names>CJ</given-names></name><name><surname>Grandits</surname><given-names>M</given-names></name><name><surname>Baechler</surname><given-names>EC</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Peripheral blood gene expression profiling in Sjogren's syndrome.</article-title>
<source>Genes Immun</source>
<volume>10</volume>
<fpage>285</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="pmid">19404300</pub-id></element-citation></ref><ref id="ppat.1002480-Conrad1"><label>40</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Conrad</surname><given-names>B</given-names></name></person-group>
<year>2003</year>
<article-title>Potential mechanisms of interferon-alpha induced autoimmunity.</article-title>
<source>Autoimmunity</source>
<volume>36</volume>
<fpage>519</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="pmid">14984029</pub-id></element-citation></ref><ref id="ppat.1002480-Levin1"><label>41</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levin</surname><given-names>MC</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Kalume</surname><given-names>F</given-names></name><name><surname>Morcos</surname><given-names>Y</given-names></name><name><surname>Dohan</surname><given-names>FC</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Autoimmunity due to molecular mimicry as a cause of neurological disease.</article-title>
<source>Nat Med</source>
<volume>8</volume>
<fpage>509</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="pmid">11984596</pub-id></element-citation></ref><ref id="ppat.1002480-Kattan1"><label>42</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kattan</surname><given-names>T</given-names></name><name><surname>MacNamara</surname><given-names>A</given-names></name><name><surname>Rowan</surname><given-names>AG</given-names></name><name><surname>Nose</surname><given-names>H</given-names></name><name><surname>Mosley</surname><given-names>AJ</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>The avidity and lytic efficiency of the CTL response to HTLV-1.</article-title>
<source>J Immunol</source>
<volume>182</volume>
<fpage>5723</fpage>
<lpage>5729</lpage>
<pub-id pub-id-type="pmid">19380819</pub-id></element-citation></ref><ref id="ppat.1002480-vanBaarsen1"><label>43</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Baarsen</surname><given-names>LGM</given-names></name><name><surname>Kraan</surname><given-names>TCTMvdP</given-names></name><name><surname>Kragt</surname><given-names>JJ</given-names></name><name><surname>Baggen</surname><given-names>JMC</given-names></name><name><surname>Rustenburg</surname><given-names>F</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>A subtype of multiple sclerosis defined by an activated immune defense program.</article-title>
<source>Genes Immun</source>
<volume>7</volume>
<fpage>522</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="pmid">16837931</pub-id></element-citation></ref><ref id="ppat.1002480-Pearlman1"><label>44</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pearlman</surname><given-names>BL</given-names></name><name><surname>Traub</surname><given-names>N</given-names></name></person-group>
<year>2011</year>
<article-title>Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More.</article-title>
<source>Clin Infect Dis</source>
<volume>52</volume>
<fpage>889</fpage>
<lpage>900</lpage>
<pub-id pub-id-type="pmid">21427396</pub-id></element-citation></ref><ref id="ppat.1002480-DhibJalbut1"><label>45</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dhib-Jalbut</surname><given-names>S</given-names></name><name><surname>Marks</surname><given-names>S</given-names></name></person-group>
<year>2010</year>
<article-title>Interferon-beta mechanisms of action in multiple sclerosis.</article-title>
<source>Neurology</source>
<volume>74</volume>
<fpage>S17</fpage>
<lpage>S24</lpage>
<pub-id pub-id-type="pmid">20038758</pub-id></element-citation></ref><ref id="ppat.1002480-Martin1"><label>46</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>F</given-names></name><name><surname>Taylor</surname><given-names>GP</given-names></name></person-group>
<year>2011</year>
<article-title>Prospects for the management of human T-cell lymphotropic virus type 1-associated myelopathy.</article-title>
<source>AIDS Rev</source>
<volume>13</volume>
<fpage>161</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="pmid">21799534</pub-id></element-citation></ref><ref id="ppat.1002480-Kinpara1"><label>47</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kinpara</surname><given-names>S</given-names></name><name><surname>Hasegawa</surname><given-names>A</given-names></name><name><surname>Utsunomiya</surname><given-names>A</given-names></name><name><surname>Nishitsuji</surname><given-names>H</given-names></name><name><surname>Furukawa</surname><given-names>H</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Stromal Cell-Mediated Suppression of Human T-Cell Leukemia Virus Type 1 Expression In Vitro and In Vivo by Type I Interferon.</article-title>
<source>J Virol</source>
<volume>83</volume>
<fpage>5101</fpage>
<lpage>5108</lpage>
<pub-id pub-id-type="pmid">19264779</pub-id></element-citation></ref><ref id="ppat.1002480-Matsuoka1"><label>48</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>M</given-names></name><name><surname>Jeang</surname><given-names>K-T</given-names></name></person-group>
<year>2007</year>
<article-title>Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.</article-title>
<source>Nat Rev Cancer</source>
<volume>7</volume>
<fpage>270</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="pmid">17384582</pub-id></element-citation></ref><ref id="ppat.1002480-Grassmann1"><label>49</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grassmann</surname><given-names>R</given-names></name><name><surname>Aboud</surname><given-names>M</given-names></name><name><surname>Jeang</surname><given-names>KT</given-names></name></person-group>
<year>2005</year>
<article-title>Molecular mechanisms of cellular transformation by HTLV-1 Tax.</article-title>
<source>Oncogene</source>
<volume>24</volume>
<fpage>5976</fpage>
<lpage>5985</lpage>
<pub-id pub-id-type="pmid">16155604</pub-id></element-citation></ref><ref id="ppat.1002480-Basbous1"><label>50</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basbous</surname><given-names>J</given-names></name><name><surname>Arpin</surname><given-names>C</given-names></name><name><surname>Gaudray</surname><given-names>G</given-names></name><name><surname>Piechaczyk</surname><given-names>M</given-names></name><name><surname>Devaux</surname><given-names>C</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity.</article-title>
<source>J Biol Chem</source>
<volume>278</volume>
<fpage>43620</fpage>
<lpage>43627</lpage>
<pub-id pub-id-type="pmid">12937177</pub-id></element-citation></ref><ref id="ppat.1002480-Matsumoto1"><label>51</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>J</given-names></name><name><surname>Ohshima</surname><given-names>T</given-names></name><name><surname>Isono</surname><given-names>O</given-names></name><name><surname>Shimotohno</surname><given-names>K</given-names></name></person-group>
<year>2005</year>
<article-title>HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.</article-title>
<source>Oncogene</source>
<volume>24</volume>
<fpage>1001</fpage>
<lpage>1010</lpage>
<pub-id pub-id-type="pmid">15592508</pub-id></element-citation></ref><ref id="ppat.1002480-Arnold1"><label>52</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arnold</surname><given-names>J</given-names></name><name><surname>Yamamoto</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Phipps</surname><given-names>AJ</given-names></name><name><surname>Younis</surname><given-names>I</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.</article-title>
<source>Blood</source>
<volume>107</volume>
<fpage>3976</fpage>
<lpage>3982</lpage>
<pub-id pub-id-type="pmid">16424388</pub-id></element-citation></ref><ref id="ppat.1002480-Saito1"><label>53</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Matsuzaki</surname><given-names>T</given-names></name><name><surname>Satou</surname><given-names>Y</given-names></name><name><surname>Yasunaga</surname><given-names>J</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).</article-title>
<source>Retrovirology</source>
<volume>6</volume>
<fpage>19</fpage>
<pub-id pub-id-type="pmid">19228429</pub-id></element-citation></ref><ref id="ppat.1002480-Feng1"><label>54</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Ratner</surname><given-names>L</given-names></name></person-group>
<year>2008</year>
<article-title>Human T-cell leukemia virus type 1 blunts signaling by interferon alpha.</article-title>
<source>Virology</source>
<volume>374</volume>
<fpage>210</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="pmid">18234266</pub-id></element-citation></ref><ref id="ppat.1002480-Charoenthongtrakul1"><label>55</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Charoenthongtrakul</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Shembade</surname><given-names>N</given-names></name><name><surname>Harhaj</surname><given-names>NS</given-names></name><name><surname>Harhaj</surname><given-names>EW</given-names></name></person-group>
<year>2011</year>
<article-title>Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1.</article-title>
<source>J Virol</source>
<volume>85</volume>
<fpage>6955</fpage>
<lpage>6962</lpage>
<pub-id pub-id-type="pmid">21593151</pub-id></element-citation></ref><ref id="ppat.1002480-Meek1"><label>56</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meek</surname><given-names>DW</given-names></name></person-group>
<year>2009</year>
<article-title>Tumour suppression by p53: a role for the DNA damage response?</article-title>
<source>Nat Rev Cancer</source>
<volume>9</volume>
<fpage>714</fpage>
<lpage>723</lpage>
<pub-id pub-id-type="pmid">19730431</pub-id></element-citation></ref><ref id="ppat.1002480-Boxus1"><label>57</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boxus</surname><given-names>M</given-names></name><name><surname>Twizere</surname><given-names>JC</given-names></name><name><surname>Legros</surname><given-names>S</given-names></name><name><surname>Dewulf</surname><given-names>JF</given-names></name><name><surname>Kettmann</surname><given-names>R</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>The HTLV-1 Tax interactome.</article-title>
<source>Retrovirology</source>
<volume>5</volume>
<fpage>76</fpage>
<pub-id pub-id-type="pmid">18702816</pub-id></element-citation></ref><ref id="ppat.1002480-Akagi1"><label>58</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Akagi</surname><given-names>T</given-names></name><name><surname>Ono</surname><given-names>H</given-names></name><name><surname>Tsuchida</surname><given-names>N</given-names></name><name><surname>Shimotohno</surname><given-names>K</given-names></name></person-group>
<year>1997</year>
<article-title>Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1.</article-title>
<source>FEBS Lett</source>
<volume>406</volume>
<fpage>263</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="pmid">9136898</pub-id></element-citation></ref><ref id="ppat.1002480-Chandhasin1"><label>59</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chandhasin</surname><given-names>C</given-names></name><name><surname>Ducu</surname><given-names>RI</given-names></name><name><surname>Berkovich</surname><given-names>E</given-names></name><name><surname>Kastan</surname><given-names>MB</given-names></name><name><surname>Marriott</surname><given-names>SJ</given-names></name></person-group>
<year>2008</year>
<article-title>Human T-cell leukemia virus type 1 Tax attenuates the ATM-mediated cellular DNA damage response.</article-title>
<source>J Virol</source>
<volume>82</volume>
<fpage>6952</fpage>
<lpage>6961</lpage>
<pub-id pub-id-type="pmid">18434398</pub-id></element-citation></ref><ref id="ppat.1002480-Chow1"><label>60</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chow</surname><given-names>S</given-names></name><name><surname>Hedley</surname><given-names>D</given-names></name><name><surname>Grom</surname><given-names>P</given-names></name><name><surname>Magari</surname><given-names>R</given-names></name><name><surname>Jacobberger</surname><given-names>JW</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations.</article-title>
<source>Cytometry A</source>
<volume>67A</volume>
<fpage>4</fpage>
<lpage>17</lpage>
</element-citation></ref><ref id="ppat.1002480-Lee1"><label>61</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Tozawa</surname><given-names>H</given-names></name></person-group>
<year>1989</year>
<article-title>Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I.</article-title>
<source>Tohoku J Exp Med</source>
<volume>157</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">2711372</pub-id></element-citation></ref><ref id="ppat.1002480-Tanaka1"><label>62</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Inoi</surname><given-names>T</given-names></name><name><surname>Tozawa</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name><etal/></person-group>
<year>1986</year>
<article-title>Antigens related to three core proteins of HTLV-I (p24, p19 and p15) and their intracellular localizations, as defined by monoclonal antibodies.</article-title>
<source>Int J Cancer</source>
<volume>37</volume>
<fpage>35</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">3000953</pub-id></element-citation></ref></